PE20080134A1 - Sal nitrato de alisquireno - Google Patents
Sal nitrato de alisquirenoInfo
- Publication number
- PE20080134A1 PE20080134A1 PE2007000196A PE2007000196A PE20080134A1 PE 20080134 A1 PE20080134 A1 PE 20080134A1 PE 2007000196 A PE2007000196 A PE 2007000196A PE 2007000196 A PE2007000196 A PE 2007000196A PE 20080134 A1 PE20080134 A1 PE 20080134A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- refers
- nitrate
- salt
- alisquiren
- Prior art date
Links
- 229910002651 NO3 Inorganic materials 0.000 title 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- -1 3-AMINO-2,2-DIMETHYL-3-OXO-PROPYL Chemical class 0.000 abstract 3
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 239000000480 calcium channel blocker Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000002823 nitrates Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
SE REFIERE A UNA SAL NITRATO DE ALISQUIRENO O (2(S),4(S),5(S),7(S)-N-(3-AMINO-2,2-DIMETIL-3-OXO-PROPIL)-2,7-DI-(1-METIL-ETIL)-4-HIDROXI-5-AMINO-8-[4-METOXI-3-(3-METOXI-PROPOXI)-FENIL]-OCTANAMIDA) EN UNA FORMA CRISTALINA, PARCIALMENTE CRISTALINA, AMORFA O POLIMORFA, CARACTERIZADA POR PRESENTAR UN ESPECTRO DE DRIFT-IR QUE TIENE LAS SIGUIENTES BANDAS EXPRESADOS EN CM-1: 358, 2960, 1665, 1516, 1388, ENTRE OTROS; UN PATRON DE DIFRACCION EN POLVO DE RAYOS X QUE COMPRENDE INTERVALOS DEL PLANO INTER-CELOSIA: d EN [Å] (+0.1 Å): 17.0, 9.6, 8.3, 7.5, 6.2, 5.8, 5.5, 4.6, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA QUE ADEMAS PUEDE PRESENTARSE EN COMBINACION CON AL MENOS UN INHIBIDOR HMG-CoA-REDUCTASA, UN BLOQUEADOR DE CANAL DE CALCIO, ENTRE OTROS. DICHO COMPUESTO ES UN INHIBIDOR DIRECTO DE LA RENINA POR LO QUE ES UTIL COMO ANTI-HIPERTENSIVO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77647406P | 2006-02-24 | 2006-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080134A1 true PE20080134A1 (es) | 2008-04-09 |
Family
ID=38438115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000196A PE20080134A1 (es) | 2006-02-24 | 2007-02-22 | Sal nitrato de alisquireno |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20090131528A1 (es) |
| EP (1) | EP1996542B1 (es) |
| JP (1) | JP2009531300A (es) |
| KR (1) | KR20080098044A (es) |
| CN (1) | CN101389598A (es) |
| AR (1) | AR059610A1 (es) |
| AT (1) | ATE518827T1 (es) |
| AU (1) | AU2007216969B2 (es) |
| BR (1) | BRPI0708217A2 (es) |
| CA (1) | CA2640723A1 (es) |
| CL (1) | CL2007000485A1 (es) |
| ES (1) | ES2367593T3 (es) |
| PE (1) | PE20080134A1 (es) |
| PL (1) | PL1996542T3 (es) |
| PT (1) | PT1996542E (es) |
| RU (1) | RU2008137725A (es) |
| TW (1) | TW200804241A (es) |
| WO (1) | WO2007098503A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1972335A1 (en) * | 2007-03-23 | 2008-09-24 | Krka | Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| AU2008303504C1 (en) * | 2007-09-28 | 2013-05-16 | Novartis Ag | Galenical formulations of Aliskiren |
| TW201008902A (en) * | 2008-05-23 | 2010-03-01 | Teva Pharma | Aliskiren monofumarate and processes for preparation thereof |
| EA201190091A1 (ru) | 2009-02-05 | 2012-01-30 | Крка, Товарна Здравил, Д. Д., Ново Место | Активируемый влагой способ грануляции |
| WO2010091277A2 (en) | 2009-02-05 | 2010-08-12 | Teva Pharmaceutical Industries Ltd. | Solid state forms of aliskiren compounds |
| CA2847736A1 (en) * | 2011-09-07 | 2013-03-14 | IVAX International GmbH | A new polymorphic form of pridopidine hydrochloride |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| US20030114389A1 (en) * | 2001-11-13 | 2003-06-19 | Webb Randy Lee | Combination of organic compounds |
| PE20060075A1 (es) * | 2004-03-17 | 2006-03-20 | Novartis Ag | Composiciones farmaceuticas de alisciren |
-
2007
- 2007-02-16 TW TW096106232A patent/TW200804241A/zh unknown
- 2007-02-22 AR ARP070100751A patent/AR059610A1/es not_active Application Discontinuation
- 2007-02-22 PE PE2007000196A patent/PE20080134A1/es not_active Application Discontinuation
- 2007-02-23 BR BRPI0708217-7A patent/BRPI0708217A2/pt not_active IP Right Cessation
- 2007-02-23 PT PT07757391T patent/PT1996542E/pt unknown
- 2007-02-23 AT AT07757391T patent/ATE518827T1/de active
- 2007-02-23 CA CA002640723A patent/CA2640723A1/en not_active Abandoned
- 2007-02-23 EP EP07757391A patent/EP1996542B1/en not_active Not-in-force
- 2007-02-23 CN CNA2007800062398A patent/CN101389598A/zh active Pending
- 2007-02-23 CL CL200700485A patent/CL2007000485A1/es unknown
- 2007-02-23 US US12/280,591 patent/US20090131528A1/en not_active Abandoned
- 2007-02-23 WO PCT/US2007/062666 patent/WO2007098503A2/en not_active Ceased
- 2007-02-23 JP JP2008556557A patent/JP2009531300A/ja not_active Withdrawn
- 2007-02-23 KR KR1020087020598A patent/KR20080098044A/ko not_active Ceased
- 2007-02-23 PL PL07757391T patent/PL1996542T3/pl unknown
- 2007-02-23 RU RU2008137725/04A patent/RU2008137725A/ru not_active Application Discontinuation
- 2007-02-23 AU AU2007216969A patent/AU2007216969B2/en not_active Ceased
- 2007-02-23 ES ES07757391T patent/ES2367593T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007098503A3 (en) | 2008-02-07 |
| ATE518827T1 (de) | 2011-08-15 |
| ES2367593T3 (es) | 2011-11-04 |
| EP1996542B1 (en) | 2011-08-03 |
| KR20080098044A (ko) | 2008-11-06 |
| RU2008137725A (ru) | 2010-03-27 |
| TW200804241A (en) | 2008-01-16 |
| AR059610A1 (es) | 2008-04-16 |
| WO2007098503A2 (en) | 2007-08-30 |
| AU2007216969A1 (en) | 2007-08-30 |
| JP2009531300A (ja) | 2009-09-03 |
| CN101389598A (zh) | 2009-03-18 |
| CL2007000485A1 (es) | 2008-03-14 |
| BRPI0708217A2 (pt) | 2011-05-17 |
| AU2007216969B2 (en) | 2010-06-24 |
| PL1996542T3 (pl) | 2011-12-30 |
| CA2640723A1 (en) | 2007-08-30 |
| EP1996542A2 (en) | 2008-12-03 |
| PT1996542E (pt) | 2011-10-03 |
| US20090131528A1 (en) | 2009-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080134A1 (es) | Sal nitrato de alisquireno | |
| AR112227A2 (es) | Sal de hemifumarato del ácido 1-(4-{1-[(e)-4-ciclohexil-3-trifluorometil-benciloxi-imino]-etil}-2-etil-bencil)-azetidin-3-carboxílico, y otras formas cristalinas de la misma | |
| ECSP088597A (es) | Sal de sulfato de hidrógeno novedosa | |
| PE20001333A1 (es) | Proceso para estabilizar macrolidos de polieno | |
| AR064809A1 (es) | Formas cristalinas | |
| CR8249A (es) | Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen | |
| ECSP066375A (es) | Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| TW200716558A (en) | Heteroaroyl-substituted serineamides | |
| BRPI0606318B8 (pt) | composto, composição, e, uso de um composto | |
| CU23999B1 (es) | Solución no-acuosa tópica de diclofenaco y proceso para su preparación | |
| EA200702586A1 (ru) | Кристаллические модификации пираклостробина | |
| PE20141062A1 (es) | Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil]benzamida (ms-275) | |
| RU2008139905A (ru) | Фармацевтическая композиция для наружного применения | |
| AR061311A1 (es) | Procesos para preparar clorhidrato de cinacalcet y formas polimorficas del mismo | |
| SG165315A1 (en) | Alpha2c adrenoreceptor agonists | |
| MY185130A (en) | Romidepsin solid forms and uses thereof | |
| BRPI0603059A (pt) | forma cristalina v de agomelatina, um processo para sua preparação e composições farmacêuticas contendo-a | |
| GT200600086A (es) | Forma cristalina de gamma-d del clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| AR057649A1 (es) | Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas | |
| PE20071016A1 (es) | Formas cristalinas de n-(benzo[b]tien-3-ilmetil)-sulfamida | |
| BRPI0603074A (pt) | forma cristalina iii de agomelatina, um processo para sua preparação e composições farmacêuticas contendo-a | |
| EA200900732A1 (ru) | Кристаллическая калиевая соль аналогов липоксина а | |
| CL2013000756A1 (es) | Forma cristalaina del citrato diacido de (4s)-4-(5-fenil-1,3,4-tiadiazol-2-iloxi)-1-azatriciclo[3.3.1.13,7]decano; proceso de preparacion; composicion farmaceutica; y su uso para tratar o prevenir un trastorno de la memoria, un trastorno cognitivo, neurodegeneracion, entre otros. | |
| PH12012501098A1 (en) | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof | |
| WO2015042414A8 (en) | Multicyclic compounds and methods of using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |